SC
BDSX icon

Stempoint Capital’s Biodesix BDSX Stock Holding History

Stempoint Capital’s Portfolio BDSX Stock Details BDSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.02M Buy
+70,004
New +$868K 0.19% 67

Other funds holding BDSX

ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
TAM
Telemark Asset Management Boston, Massachusetts $1.08B AUM 70.88% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
EIM
Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return
TI
Trexquant Investment Stamford, Connecticut $13.9B AUM 31.98% 1-Year Est. Return

Stempoint Capital's BDSX Position: Q1 2026 in Review

Stempoint Capital opened a new position in Biodesix (BDSX) in Q1 2026: 70,004 shares worth $1.02M. The stake represents 0.19% of the portfolio and ranks #67 among its holdings.

40 funds tracked by Wall St. Rank hold BDSX as of Q1 2026.

  • Stempoint Capital held 70,004 shares of Biodesix worth $1.02M as of Q1 2026.
  • Biodesix was a new Stempoint Capital position in Q1 2026.
  • Biodesix made up 0.19% of Stempoint Capital's portfolio in Q1 2026, its #67 holding.
  • 40 funds tracked by Wall St. Rank held Biodesix as of Q1 2026.

Based on Stempoint Capital's 13F filing for Q1 2026, filed 15 May 2026.